Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2026-06-15 18:50:54 ET · period of report 2026-06-15 · accession 0001796536-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 18:50 | 2026-06-15 | RARE | Sanders Corazon (Corsee) D. | Dir | S - Sale | $25.05 | -2,000 | 21.1K | -9% | -$50.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-15 | S | D | 2,000 | $25.05 | 21,095 | D | — | — | (F1) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |